Mycobacterium szulgai: An Unusual Pathogen

Publisher Website
Google Scholar
Abstract
Mycobacterium szulgai is an unusual pathogen that accounts for M. szulgai requires different management, and it is therefore important to distinguish disease caused by M. szulgai from that caused by M. tuberculosis. Isolation of M. szulgai implies the presence of clinical disease, and when the organism is identified, treatment based on sensitivity testing should be initiated. Although no standard recommendations for treatment exist, most infections due to M szulgai have been treated with combined high doses of isoniazid, ethambutol, and rifampin for 18–24 months. M. szulgai has been isolated worldwide; the first case of infection reported from Canada is described, and the clinical presentation, microbiologic diagnosis, and therapeutic management of M. szulgai infections are reviewed.

This publication has 0 references indexed in Scilit: